TNFSF13B and B-cell chronic lymphocytic leukemia: MiR-155 overexpression has oncogenic activity in CLL, and its dysregulation can be triggered by microenvironment signals such as BAFF binding to its receptor BAFF-L on the CLL cell surface [61].